[1]
A. Wsół and A. Mamcarz, “Comparison of clinical effectiveness of ezetymib/simvastatin combination v. atorvastatin and rosuvastatin in achievement the Joint British Societies (JBS)-2 low density-lipoprotein cholesterol (LDL-C) target ? UK General Practice Trial (IN-PRACTICE)”, J EBM, vol. 3, no. 3(8), pp. 6-11, Sep. 2010.